Investor & Distributor Overview

Azurith Labs presents HYDRYON™.

HYDRYON™ is the lead Azurith Labs topical skin health platform built around controlled oxidative biology, commercial launch discipline, and scalable access across consumer, wholesale, distributor, and professional channels.

58M+ U.S. patients with actinic keratoses
$8.9B annual U.S. NMSC treatment cost
5.4M+ new NMSC diagnoses per year
$29.79 HYDRYON™ 12-packet box
HYDRYON™ Investor Video · Known Science. Smarter Execution. Accessible Preventive Care.
Launch Product

HYDRYON™ 12-Packet Box priced at $29.79.

The customer-facing launch product is one HYDRYON™ box containing twelve individual packets, priced at $29.79. This gives investors and distributors a simple, clear, scalable product unit for ecommerce, wholesale planning, retail discussions, and repeat-purchase modeling.

HYDRYON 12-packet box

HYDRYON™ 12-Packet Box

HYDRYON™ by Azurith Labs is sold as one convenient product box containing twelve individual packets. The packet format supports clean presentation, simple customer understanding, ecommerce checkout, retail merchandising, and distributor conversations.

$29.79 / 12-packet box

At approximately $2.48 per packet, the product can be positioned as an accessible premium skin wellness purchase while preserving room for wholesale pricing, distributor margin, affiliate programs, retail testing, and subscription modeling.

12 individual packets Consumer-ready SKU Wholesale-ready format Repeat-purchase potential
Product pricing, checkout, taxes, shipping, availability, label directions, warnings, refund rules, and claims should be reviewed before public launch or investor distribution.
Market Opportunity

A large, visible market with strong access pressure.

HYDRYON™ is positioned around actinic keratoses, non-melanoma skin cancer burden, and global distribution potential. The investor dossier highlights more than 58 million U.S. patients with actinic keratoses, $8.9 billion in annual U.S. NMSC treatment cost, and more than 5.4 million new NMSC diagnoses per year.

Actinic Keratoses Scale

AK affects an estimated 58 million Americans, creating a high-volume market where earlier, accessible skin health intervention is commercially meaningful.

NMSC Treatment Cost

The dossier cites $8.9B+ in annual U.S. non-melanoma skin cancer treatment cost, underscoring the economic pressure surrounding reactive skin lesion management.

Global Distribution

International distribution, retail, pharmacy, professional, institutional, and consumer channels create multiple expansion paths for a standardized product platform.

Science & Platform Thesis

Controlled oxidative biology translated into a product platform.

HYDRYON™ is positioned around the biological asymmetry between healthy keratinocytes and dysregulated keratinocytes. The company thesis is that controlled oxidative stress, properly formulated and delivered, can become a scalable skin health platform.

Mechanism-Driven

The platform narrative focuses on catalase activity, oxidative vulnerability, and controlled topical delivery rather than generic commodity peroxide positioning.

Execution-Ready Thesis

Azurith Labs is being built around execution: product presentation, launch infrastructure, channel development, investor materials, distributor conversations, and scalable ecommerce.

Platform Expansion

HYDRYON™ is presented as the lead product, with potential adjacent platform extensions across skin health, oral health, and wound-care-adjacent categories subject to review.

Scientific, regulatory, clinical, therapeutic, disease, and product-performance statements must be reviewed by qualified legal, regulatory, medical, and scientific advisors before public or commercial use.
Commercial Model

Multi-channel commercialization with a simple front-end product.

The $29.79 HYDRYON™ 12-packet box creates a clear entry SKU for direct-to-consumer ecommerce, affiliate marketing, wholesale outreach, distributor planning, professional education, and retail channel testing.

1

DTC Website

Launch through AzurithLabs.com with product education, video, checkout, legal pages, and customer support.

2

Affiliate & Influencer

Education-led referral channels can support awareness, discovery, and performance-based acquisition.

3

Wholesale / Retail

The packet box format supports retail presentation, distributor margins, and controlled rollout.

4

Professional Channels

Dermatology-adjacent, wellness, pharmacy, and professional education channels can expand credibility.

5

Institutional Buyers

Employer, occupational health, public health, and institutional conversations can be evaluated as evidence matures.

6

Pipeline Expansion

The same platform logic may support adjacent product extensions and additional channel strategies.

Investor Thesis

The opportunity is execution around known biology and unmet access.

HYDRYON™ is positioned as a platform opportunity: a lead product with an accessible consumer SKU, a mechanism-driven story, multiple channel paths, and potential expansion into wholesale, retail, distributor, institutional, and professional markets.

Why investors care

  • Large market pressure around skin lesion care and prevention.
  • Simple $29.79 12-packet launch product for customer testing.
  • Premium wellness / OTC-adjacent positioning potential.
  • Multiple expansion channels beyond one ecommerce page.

Why distributors care

  • Clear SKU format: one box, twelve packets.
  • Retail-friendly product presentation.
  • Education-led marketing story.
  • Wholesale and distributor terms can be structured separately.
Investor Summary

View the HYDRYON™ Investor Summary.

Review the Azurith Labs / HYDRYON™ Investor Offering PDF for the product summary, market opportunity, commercialization pathway, investor thesis, distributor opportunity, pricing model, and business discussion.

HYDRYON™ Investor Offering PDF

The investor summary is available as a PDF for review by appropriate investors, distributors, wholesale buyers, strategic partners, and qualified business contacts.

Offering Review Notice

This page and investor PDF are for discussion only. They do not constitute a securities offering, investment recommendation, medical advice, product approval, or regulatory clearance.

Securities, investment, regulatory, medical, product-claim, labeling, forward-looking, and distribution statements should be reviewed by qualified advisors before use.
HYDRYON™ product identity, price, claims, directions, warnings, regulatory pathway, availability, checkout, fulfillment, and commercial language are subject to review.
Investor, Distributor & Wholesale Contact

Start the conversation with Azurith Labs.

Azurith Labs welcomes appropriate inquiries regarding investment, distribution, wholesale, retail, professional, institutional, and strategic partnership opportunities.

Investor Inquiry

Request investor materials, financial discussion, qualified review, or a management conversation.

Distributor Inquiry

Discuss regional distribution, wholesale volume, retail channels, professional markets, or international rollout.

Wholesale / Retail

Explore wholesale pricing, retail presentation, launch bundles, pharmacy channels, and reseller terms.

Contacting Azurith Labs does not create an investment relationship, distribution agreement, reseller agreement, advisory relationship, or medical relationship. All terms are subject to review, diligence, documentation, compliance, and approval.
Azurith Labs · HYDRYON™ Investor Page
Español